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Abstract
 
Gene-targeted mice were generated with a loxP-neomycin resistance gene (neo
 
r
 
) cassette in-
serted upstream of the J
 
l
 
1 region and replacement of the glycine 154 codon in the C
 
l
 
1 gene
with a serine codon. This insertion dramatically increases V
 
l
 
1-J
 
l
 
1 recombination. J
 
l
 
1 germ-
line transcription levels in pre-B cells and thymus cells are also greatly increased, apparently due
to the strong housekeeping phosphoglycerine kinase (PGK) promoter driving the neo gene. In
contrast, deletion of the neo
 
 
 
gene causes a significant decrease in VJ
 
l
 
1 recombination to levels
below those in normal mice. This reduction is due to the loxP site left on the chromosome
which reduces the J
 
l
 
1 germline transcription in cis. Thus, the correlation between germline
transcription and variable (V), diversity (D), and joining (J) recombination is not just an all or
none phenomenon. Rather, the transcription efficiency is directly associated with the recombi-
nation efficiency. Furthermore, J
 
l
 
1 and V
 
l
 
1 germline transcription itself is not sufficient to
lead to VJ recombination in T cells or early pre-B cells. The findings may suggest that in vivo:
(a) locus and cell type–specific transactivators direct the immunoglobulin or T cell receptor
loci, respectively, to a “recombination factory” in the nucleus, and (b) transcription complexes
deliver V(D)J recombinase to the recombination signal sequences.
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Introduction
 
The Ig and TCR gene loci are composed of V, D, and J
gene segments. During lymphocyte development, these
segments somatically recombine to form a functional Ig or
TCR gene. This V(D)J recombination is initiated by re-
combination activating gene (RAG)1/RAG2 proteins and
processed by a double strand break repair complex in-
volving DNA-dependent protein kinase catalytic subunit
(DNA-PKcs), Ku70/80, x-ray repair complementing de-
fective repair in Chinese hamster cells (XRCC4), and
DNA ligase IV (1, 2). The recombination signal sequences
(RSSs)
 
1
 
 which mediate this lymphocyte-specific recombi-
nation are highly conserved in all the antigen receptor gene
segments. Given the conserved RSSs and the same recom-
bination mechanism, the cell type– and stage-specific
V(D)J recombination events must be regulated by lineage-
specific (B versus T cells) and developmental stage–specific
(pre- versus mature cells) accessibility mechanisms (3).
The current model for these lineage- and stage-specific
accessibilities holds that the chromatin in different antigen
receptor loci is opened in the appropriate cell lineage at the
appropriate cell stage so that the V(D)J recombination
complexes can be loaded and begin functioning (4, 5).
The transcriptional enhancers in the Ig
 
k
 
, IgH, and TCR
genes have been shown to be essential for V(D)J recombi-
nation (6–11). Antigen receptor loci generate weak germ-
line transcripts at the time when they are recombined (3,
12). For instance, germline transcripts have been observed
from Ig heavy chain and 
 
k
 
 light chain regions at the same
time as their rearrangement (6, 13–16). In a recent paper,
the J
 
l
 
 regions were shown to generate germline transcripts
at the small pre-B cell stage when the Ig
 
l
 
 genes presum-
ably start to rearrange (17). Even though the germline
transcription event is highly correlated with the V(D)J re-
combination, whether the germline transcription is the
cause or a consequence of the chromatin opening is still in
debate.
Recent studies have demonstrated that the neomycin re-
sistance gene (neo
 
r
 
),
 
 
 
when inserted in the JC intron in the
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Ig Gene Accessibility
 
Ig heavy chain or 
 
k
 
 locus, generally severely inhibits V(D)J
recombination (3, 9, 10, 18–20). The inhibition had been
explained by postulating that the strong phosphoglycerine
kinase (PGK) promoter interacts with Ig enhancer binding
transactivating proteins and thus prevents V(D)J recombi-
nation either by preventing the transcription of sterile (germ-
line) transcripts, preventing chromatin remodeling, pre-
venting the binding of V(D)J recombinase–associated
components to the Ig enhancers, or a combination of these
(3). The inhibition was clearly due to the PGK-neo gene,
as its removal by cre-loxP recombination reduced the inhi-
bition. Unfortunately, the effect of PGK-neo on local germ-
line transcription was not examined in these studies.
We have created knock-in mice in which a loxP-neo
 
r
 
cassette was inserted upstream of the J
 
l
 
1 region. The tar-
geted allele can be distinguished from the wild-type allele
by a serine codon replacing a glycine codon normally
present at position 154 of C
 
l
 
1. The wild-type C
 
l
 
1 gene
can be cut by KpnI/Asp718 at this position, but the tar-
geted allele can not. Serine is present in human and chim-
panzee 
 
l
 
 chains at this position (21). The knock-in mice
showed an enormous increase in 
 
l
 
1 B cells which, as we
report here, is due to the inserted neo gene driven by the
PGK transcriptional promoter.
 
Materials and Methods
 
Targeting Vector and Embryonic Stem Clone Screening.
 
The orig-
inal DNA construct, J3-C1 knockout, was a gift from Dr. D.
Huszar, formerly of GenPharm International (San Jose, CA). In
this plasmid, the region from the J
 
l
 
3 exon to part of the C
 
l
 
1
exon was replaced by a phosphoglycerate kinase promoter–driven
puromycin resistance gene (PGK-puro). It was flanked by 4.2 and
4.4 kb of 129S5/SvEvBrd genomic DNA. A PGK promoter–
driven thymidine kinase gene (PGK-tk) was located at the 5
 
9
 
 end
of the DNA. To make the targeting vector, a 5.3-kb NheI frag-
ment carrying the J
 
l
 
3 to C
 
l
 
1 region from a BALB/c genomic
clone (22) was first subcloned. A NotI-XhoI fragment from the
ploxPneo-1 plasmid (a gift of Dr. A. Nagy, Mount Sinai Hospital,
Toronto, Canada [23]) contains a neomycin phosphotransferase
(neo) gene, driven by the PGK promoter, terminated by the PGK
polyadenylation site, and flanked by two loxP sites. This fragment
(loxP-neo) was inserted at the NdeI site, 
 
z
 
100 bp upstream of the
RSS of J
 
l
 
1 in such a way that the neo transcription is toward
the J1C1 of the Ig
 
l
 
 locus. Point mutations were introduced into
the C
 
l
 
1 constant region, changing a glycine codon (GGT) at po-
sition 154 of the 
 
l
 
1 chain to a serine codon (AGC). This muta-
tion disrupts a Kpn1/Asp718 restriction site. The 7.4-kb NheI
fragment containing loxP-neo and the altered C
 
l
 
1 was then used
to replace the NheI fragment containing the PGK-puro in the
J
 
l
 
3-C
 
l
 
1 knockout plasmid to generate the targeting vector (see
Fig. 1 A). The linearized targeting vector was electroporated into
AB2.2 embryonic stem (ES) cells (purchased from Lexicon com-
pany), and G418- and gancyclovir-resistant clones were selected
and further screened by Southern blotting. Two independent
clones out of 360 were obtained and injected into C57BL/6 blas-
tocysts to make chimeric mice.
For the screening of positive ES clones, the manual from Lexi-
con company was followed. The ES cell DNA was digested by
HindIII and Asp718 (Boehringer) and the filters were hybridized
with a 3
 
9
 
 C
 
l
 
1 probe (see Fig. 1 A, probe C) first (see Fig. 1 C).
 
They were then stripped and rehybridized with a neo probe (see
Fig. 1 A, probe A) to confirm the homologous recombination.
The DNAs from positive clones were also digested with XhoI
and hybridized with a neo probe for further confirmation of cor-
rect targeting.
 
Mutant Mice.
 
Germline transmitting mice were generated by
mating of chimeras with C57BL/6 mice. To generate a 
 
k
 
2
 
/
 
2
 
background, the mice were bred with 
 
k
 
-knockout mice (19, 24).
To delete the PGK-neo gene, the 
 
k
 
2
 
/
 
2
 
, 
 
l
 
1-targeted mice were
bred with a cre transgenic mouse line. The EIIa-cre transgenic
mice (gift from Dr. Westphal, National Institutes of Health, Be-
thesda, MD [25]) were originally on the FVB background, which
has low 
 
l
 
1 expression. They were bred with 
 
k
 
2
 
/
 
2
 
, 
 
l
 
1 wild-type
mice first to generate 
 
k
 
2
 
/
 
2
 
, cre transgenic mice with normal 
 
l
 
1
expression. The mice were tested to have normal 
 
l
 
1 expression
by serum analysis before breeding with the targeted mice and fur-
ther verified by FACS
 
®
 
 analysis of their spleen cells after the
breedings (data not shown). The cre transgene was screened by
PCR using primers: 5
 
9 
 
cre1, 5
 
9
 
-GGTTTCCCGCAGAACCT-
GAAGATG-3
 
9
 
 and 3
 
9 
 
cre1, 5
 
9
 
-CATTCTCCCACCGTCAG-
TACGTGAG-3
 
9
 
. The 
 
k
 
2
 
/
 
2
 
, cre transgenic, and 
 
k
 
2
 
/
 
2
 
, S-n/S-n
mice were bred together to delete the PGK-neo gene. It took
two to three breedings to completely eliminate the PGK-neo
gene from the germline (25). To analyze the neo-deleted mice,
mouse spleens were always bisected. Southern blot analysis of
DNA from one-half of each spleen was used to check the effi-
ciency of the PGK-neo deletion, while the other half was used to
do the FACS
 
®
 
 analysis. The results shown in this paper were all
done after complete neo deletion. The mouse designations are S-n
and S, for neo containing and neo deleted, respectively.
 
Southern Blot Analysis.
 
DNA isolation from mouse tissues was
performed as described (24). The genotype of the 
 
k
 
 loci was re-
vealed by hybridizing with an EcoRI-XbaI fragment from p
 
k
 
RI/
XbaI (19). To determine the genotypes, rearrangement, and ex-
pression levels of the 
 
l
 
1 locus, a 1.0-kb BglII-SmaI fragment
containing the 
 
neo
 
 structural gene (neo; Fig. 1 A, probe A) from
Tn5 neo, a 1.2-kb XbaI-KpnI fragment (J1XbaI-C1KpnI, probe
B) in the J
 
l
 
1 to C
 
l
 
1 region and a 0.4-kb EcoRI-HindIII frag-
ment (3
 
9 
 
C
 
l
 
1, probe C), 4 kb downstream of the C
 
l
 
1 exon (26),
were used. For quantitation of the Southern blotting signals, the
filters were scanned on a PhosphorImager and analyzed by Im-
ageQuant v1.2 software (Molecular Dynamics).
 
Flow Cytometry and Cell Sorting.
 
Bone marrow and spleen
tissues were disaggregated using a nylon cell strainer (Becton
Dickinson). Red blood cells were then lysed by hypotonic
shock. The cell debris was removed by a nylon strainer. Anti-
CD16/CD32 monoclonal antibody (clone 2.4G2; BD Phar-
Mingen) was first used to block the Fc
 
g
 
 receptors. Cells were
then stained (10
 
6
 
 cells/staining) in the staining buffer (DMEM,
free of serum, with 0.1% BSA) with the respective antibodies.
Fluorescence analysis was performed on a FACScan™ (Becton
Dickinson) and analyzed by CELLQuest™ software. The cells
were gated for lymphocytes by forward and side scatter and a
total of 10,000 events were collected for each staining. For pre-
parative cell sorting, the stained cells were sorted using a FAC-
Star
 
Plus™
 
 (Becton Dickinson). Large and small pre-B cells were
sorted as B220
 
1
 
IgM
 
2
 
CD25
 
1
 
 distinguished by cell size (forward
scatter; reference 17). Pre-B cells were sorted as B220
 
1
 
 and
IgM
 
2
 
 cells.
For the reverse transcription (RT)-PCR of the thymus RNA in
Fig. 6, cells from an Ig
 
k
 
-deficient, 
 
l
 
1 G/S-n mouse thymus were
disaggregated as described above. RNA was extracted from these
freshly isolated cells. T cell content was verified by staining with 
701
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anti-CD4, CD8 antibodies. Anti-CD19 antibody staining showed
that there were 
 
,
 
0.5% B cells, if any, in the thymus sample.
The following antibodies were used for staining: Cy-Chrome–
conjugated anti-B220 (RA3-6B2), FITC-labeled anti-IgM
(Southern Biotechnology Associates, Inc.), PE-labeled anti-
CD25 (PC61), PE-labeled anti-CD4, FITC-labeled anti-CD8,
and FITC-labeled anti-CD19 (all from BD PharMingen, unless
described otherwise). 
 
l
 
1 B cells were revealed by biotinylated
L22.18.2 monoclonal antibodies (24, 27) with PE-labeled strepta-
vidin (BD PharMingen) as the secondary reagent. 
 
l
 
2 and 
 
l
 
3 B
cells were revealed by FITC-labeled anti-
 
l
 
2/3 antibody (2B6;
references 17 and 28).
 
RNA Preparation.
 
Freshly harvested cells were homogenized
in 1 ml of STAT-60 containing phenol and guanidinium thiocy-
anate (Tel-Test). The RNA was extracted, precipitated, and re-
suspended in diethylpyrocarbonate-treated water.
 
PCR, RT-PCR, and Sequence Analysis.
 
The sequences of
the primers used for these assays are: 5
 
9
 
Nreg, 5
 
9
 
-CGCGAAT-
TCTCAGGCTCCCTGATTGGAGACAAGG-3
 
9
 
; 3
 
9
 
Nreg, 5
 
9
 
-
GCGGCAAGCTTTCCCAGCCTCTGTGCTGAATGTTC-
TG-3
 
9
 
; St
 
l
 
1, 5
 
9
 
-CTTGAGAATAAAATGCATGCAAGG-3
 
9
 
;
3
 
9
 
J3C1, 5
 
9
 
-GACCTAGGAACAGTCAGCACGGG-3
 
9
 
; JM001,
5
 
9
 
-TTTTCTGGAAAGACTTCCTATGAGG-39; JM005, 59-
TGGAAAATTCATGAATTATTTTCTG-39; JM002, 59-CC-
ATACCAAGTATGGAAAATTCATG-39; JM006, 59-TGC-
TCTCTCCTGAAGTGCCTCAGATG-39; JM015, 59-GAT-
GTGGATAGATACTGATGACTGTG-39; JM014, 59-TTG-
GCAATGATTCTACCTTGTGTAGG-39; JM012, 59-GAAT-
GCCTAGGTATTATAGTAAACATC-39; JM007, 59-
CCCTATATCATGTTAAGAAAGCTGATCCC-39; JM008,
59-CACAGCAATGTTCCTTCTGGAGACAGCC-39; JM009,
59-CCTCTCTAACTCATAAGTAACATGGAC-39; JM010,
59-CAAGGATGACTGAGTGTGACCTGTGAGC-39; JM011,
59-GAGTAAGTACCAGGACAGTGAAGGC-39; VL1L, 59-
GTTTGTGAATTATGGCCTGGAT-39; VL1RSS, 59-GATG-
TAGCCACCTGTTAAGAAAG-39; VL1Lin, 59-TACTCTCT-
CTCCTGGCTCTCAGCTC-39; 39PNR-2, 59- CCGTCGAC-
GACCTGCAACCAAGCTA-39; 59b-actin, 59-GTGGGC-
CGCTCTAGGCACCAA-39; and 39b-actin, 59-CTCTTTGA-
TGTCACGCACGATTTC-39.
The positions of PCR and RT-PCR primers in the l locus are
indicated in Figs. 5 A, 6 A, and 7 A. To distinguish the rearrange-
ments in splenic and sorted l B cells in various mice, PCR with
the primers 59Nreg and 39J3C1 were used. The cycling condi-
tions for the reactions were optimized to assure linear amplifica-
tion. PCR conditions were as follows: 948C for 30 s, 588C for 30 s,
and 728C for 2 min, with 28–35 cycle times. To clone and se-
quence the VJ junction in S-n/S-n splenic DNA and sorted G/S
l B cell DNA, primer sets 59Nreg/39Nreg and 59Nreg/39J3C1
were used, respectively. The PCR products were cloned into
the pCR-BluntII-TOPO vector and sequenced according to the
manufacturer’s instructions (Invitrogen). In the RT reactions, the
first strand cDNA was generated by using an oligo-dT primer. To
obtain RT-PCR products of germline transcripts of the Jl locus,
primers Stl1 (17) and 39J3C1 were used in the following PCR
condition: 948C for 20 s, 558C for 30 s, and 728C for 20 s, cycled
30–35 times. All reactions were done in two dilutions. In compar-
ing the transcripts from the targeted and the wild-type alleles, het-
erozygous mice were used and primers chosen so that the two
products only differ by two internal nucleotides. The allele-spe-
cific cDNAs were distinguished by subsequent restriction cutting
of the wild-type product; it is thus unlikely that the PCR reaction
was skewed for one or the other cDNA.
To determine the position of the germline promoter of the
Jl1 region in the wild-type allele, a series of endogenous primers
upstream of the Jl1 exon (JM000s) were used (see Fig. 6 A).
They were paired with the 39J3C1 primer for RT-PCR with
pre-B cell RNA from a Igk knock-out l1 wild-type mouse.
RT-PCR condition: 948C for 30 s, 558C for 30 s, and 728C for 2
min, 30 s, 35 cycles. The efficiencies of these primers were tested
in PCR reactions using the same condition with kidney DNA
from a wild-type mouse.
To determine transcription from the Jl1 germline promoter in
the targeted allele, RT-PCR was performed with the primers
JM001 and 39PNR-2 (see Fig. 6 A). RT-PCR condition: 948C
for 30 s, 558C for 30 s, and 728C for 1 min, 35 cycles. The b-actin
RT-PCR was performed according to the manufacturer’s pro-
tocol (CLONTECH Laboratories, Inc.) with 59b-actin and
39b-actin primers.
For all the Asp718 digestions of PCR and RT-PCR products,
the G/G samples were always used as the efficient digestion con-
trol. Normally, 8 ml PCR product were digested with Asp718 at
378C overnight. To increase the sensitivity of the assay, after the
electrophoresis, the samples were transferred onto a nylon filter
and hybridized with the specific radiolabeled probes (see Fig. 1 A).
Results
Targeted Insertion of PGK-Neo Upstream of the Jl1 Re-
gion. We generated mutant AB2.2 ES cells in which the
loxP-flanked PGK-neo cassette was inserted 100 bp up-
stream of the Jl1 RSS region (Fig. 1, A–C). The PGK-neo
was inserted in the same transcriptional orientation as the
JCl1 region. Two point mutations were introduced at
amino acid position 154 of the Cl1 gene, changing a gly-
cine codon into a serine codon. The mutations disrupt a
KpnI/Asp718 restriction site so that the targeted allele and
the wild-type allele can be easily distinguished. Mutant ES
cells were injected into C57BL/6 blastocysts to create tar-
geted mice containing the serine codon and neo (Fig. 1 D).
Germline transmitting mutant mice were further crossed
with Igk knockout mice (19) to result in a homozygous
k-knockout background. In this way only l light chains
were produced, facilitating their analysis, as normally l1 B
cells represent only 5% of the total B cells. The work de-
scribed here was done with mice with a k knockout back-
ground unless described otherwise. To eliminate PGK-neo
by Cre/loxP recombination, EIIa-cre transgenic mice (25)
were bred with the serine-targeted mice to generate PGK-
neo deleted mice (Fig. 1 D; S/S). The neo targeted allele is
named S-n (serine-neo), and after neo deletion it is named
S. The wild-type allele is named G (glycine).
Gene-targeted Mice Have Greatly Increased l1 B Cell Num-
bers. Bone marrow and splenic B cells from k2/2 and l1
wild-type (G/G), heterozygous (G/S-n), or homozygous
(S-n/S-n) mice were analyzed by FACS®. Surprisingly,
compared with wild-type mice, the l1 B cell numbers in
the G/S-n heterozygous mice are greatly increased both in
bone marrow and spleen (Fig. 2 A). The homozygous S-n/
S-n mice have an even greater enhancement (Fig. 2 A). Al-
though in wild-type mice the ratio of l1 to l2/3 B cells in
the bone marrow and spleen is 1.5 and 1.1, respectively,702 Ig Gene Accessibility
the ratio in homozygous knock-in mice, l1 S-n/S-n, is
14.9 and 11.9. Six independent pairs of mice were analyzed
by FACS®; the l1 B cell percentages in S-n/S-n mice in-
crease dramatically in all cases (Fig. 2 B). On average, the
l1 wild-type G/G mice have 54% l1 B cells, but the mu-
tant S-n/S-n mice have 82%. We also checked the pro-,
pre-B cell stages and no difference was found between S-n/
S-n and G/G (data not shown).
In k wild-type mice with the S-n/S-n l1 locus (Table
I), the k B cell number seems to be downregulated at the
same time as the l B cell number increases, altering the k/l
ratio from 20:1 to 8:1. The total lymphocyte number seems
also decreased, which may be caused by the less efficient
development of l B cells than k B cells due to selection.
Indeed, in k knockout mice with wild-type l locus, where
all B cells are l producing, the total B cell number de-
creases to z50% of normal (29).
High Levels of VJ Recombination in the Targeted Allele.
We next examined whether rearrangement is increased in
the targeted allele. As the serine mutation disrupts a KpnI/
Asp718 restriction site, the rearranged targeted allele can be
distinguished from the wild-type allele by EcoRI and
Asp718 double digestion (Fig. 2 C). In the spleen of the l1
heterozygous G/S-n mouse, there is a twofold stronger re-
arranged band from the targeted allele than from the wild-
type allele. This finding was made in repeated analyses.
This effect is further confirmed by semiquantitative PCR
of the splenic DNA from a heterozygous mouse (see Fig. 5
B, G/S-n). The PCR analysis shows a much greater differ-
ence between the wild-type and targeted band than the
Southern blot (z53); presumably in the latter, the large
band size difference gives a less accurate comparison. The
two serine point mutations in the targeted allele are 200 bp
away from the downstream PCR primer and are unlikely
to have any effect on the PCR reaction. Thus, the high l1
expression in these B cells is due to the targeted allele in cis.
It could be either caused by the PGK-neo insertion or by
the serine knock-in mutation in that allele.
As expected, no rearrangement of either the wild-type
or the targeted l1 allele is seen in thymus (Fig. 2 C).
Figure 1. Gene targeting of the Igl1 locus in ES cells and mice. (A) Strategy for
the gene targeting. A general map of the Igl locus is shown at the top. In the target-
ing vector, a PGK-neo cassette flanked by two loxP sites (shown as black triangles)
was inserted z100 bp upstream of Jl1 RSS region. Two point mutations (*) were
introduced into the Cl1 exon at amino acid position 154 disrupting a KpnI/Asp718
restriction site. Also indicated with black bars (A, B, or C) are probes used in this
study. See Materials and Methods for other details. Cre recombinase was introduced
by breeding the targeted mice with the Cre transgenic mice. The restriction sites
relevant to the figures in this paper are shown as O (XhoI), X (XbaI), H (HindIII),
K (KpnI/Asp718), and E (EcoRI). E2-4, and E3-1 are the l enhancers. (B) The sequences in the Cl1 region where the point mutations were introduced.
A glycine codon (GGT) was replaced by a serine codon (AGC) at position 154. (C) Southern blot with the 39C1 probe (A, probe C) on the HindIII-
Asp718–digested ES cell DNA from two targeted cell clones (G/S-n) and wild-type cells (G/G). The targeted allele (S-n) gives a 8-kb band, whereas the
wild-type allele (G) gives a 4.7-kb band. (D) Southern blot carried out with the 39C1 probe on HindIII-Asp718–digested kidney DNA from k2/2, l1
wild-type (G/G), heterozygous-targeted (G/S-n), homozygous-targeted (S-n/S-n), heterozygous-targeted with neo deletion (G/S), and homozygous with
neo deletion (S/S) mice. After neo deletion the targeted allele (S) gives a 5.9-kb band.703 Sun and Storb
Figure 2. l1 B cells in bone marrow and spleen of mice with the Neo
insertion. (A) Bone marrow and spleen cells from k2/2 G/G, G/S-n, and
S-n/S-n mice were double-stained with FITC-conjugated anti-l21l3 an-
tibody and biotin-coupled anti-l1 antibody (revealed by PE-coupled
streptavidin) and analyzed by flow cytometry. Lymphoid cells were gated
by forward and side scatter. The numbers indicate the percentages of the
particular cell population among all the gated lymphoid cells. (B) The per-
centages of l1 B cells among the total splenic B cells in the k2/2 G/G vs.
S-n/S-n mice. The results from six independent FACS® analyses are
shown. Three littermates as well as three nonlittermates are included. (C)
Southern blot with the J1XbaI-C1KpnI probe (see Fig. 1 A, probe B) on
EcoRI-Asp718–digested thymus and spleen DNA from k2/2 G/G, G/S-n,
and S-n/S-n mice. The germline bands are indicated as “GL” and the rear-
ranged bands are indicated as “R.” The targeted allele and nontargeted al-
lele are indicated as “S-n” and “G”, respectively. The probe cross-reacts
with a germline band from the pseudogene JCl4 and therefore the l4 band
was used as the loading control of the experiment.
Table I. l B Cell Numbers in k Wild-type Mice
Genotype N
Total
nucleated cells
Total
lymphocytes
k B cell
numbers
l B cell
numbers N9
Percentage of
k B cell 
Percentage of
l B cell 
G/G 4 80 6 15.5 59.20 6 16.10 37.75 6 13.85 1.86 6 0.43 6 63.01 6 8.41 3.38 6 0.59
G/S-n 22 2 2 23 53.70 6 6.86 5.30 6 0.44
S-n/S-n 4 70.5 6 18.41 50.48 6 18.33 22.76 6 4.27 3.45 6 1.38 5 50.98 6 13.59 6.55 6 1.24
The splenic cell numbers were determined in G/G, G/S-n, and S-n/S-n mice on the k wild-type background. “N” stands for the total number of
mice in which the total spleen cell numbers were counted. “N9” stands for the total number of mice analyzed, including some in which the total
nucleated cell numbers were not determined; thus, N9 is greater than N. The unit of the cell number is 106. The average numbers are followed by
the SEM. Total lymphocyte numbers were calculated by forward and side scatter gating in FACS® analysis. k and l B cells are determined by double-
color fluorescence staining using polyclonal antibodies. The percentages of k and l B cells are per total lymphocytes.704 Ig Gene Accessibility
The PGK-Neo Cassette Is the Cause of the Higher VJ
Recombination in the Targeted l1 Locus. The serine codon
mutation, consisting of two single nucleotide changes, is
1.3 kb away from the Jl1 RSS making it unlikely that it af-
fects VJ recombination. However, the serine codon could
affect l1 B cell receptor activity and therefore l1 B cell de-
velopment. On the other hand, PGK-neo, which is located
between the Vl1 and Jl1 region, could only affect VJ re-
combination and not l1 transcription, as PGK-neo will be
deleted by VJ recombination. To determine if the PGK-
neo leads to the high l1 expression, the loxP-flanked neo
gene was deleted from the germline of targeted mice by
breeding with cre transgenic mice (see Materials and Meth-
ods). This cre transgene is expressed throughout life in all
cells, starting in the early embryo (25). After 2–3 breedings
with the cre transgenic mice, the targeted mice had com-
pletely lost the PGK-neo cassette from the germline.
Southern blotting of the splenic DNA (similar to Fig. 1 D,
data not shown) demonstrates that the 8-kb band (S-n,
with neo insertion) is replaced by a 5.9-kb band (S, with-
out neo). Flow cytometric analysis of the splenocytes from
the cre transgenic offspring shows that the percentage of l1
B cells is reduced from 63.6% (34.41% l1/54.05% total B)
to 38.8% in G/S versus G/S-n mice and from 92.2 to
15.8% in S/S versus S-n/S-n mice (compare Figs. 3 and 2
A). Therefore, the PGK-neo gene in the targeted allele
greatly increases VJ recombination at that allele. We also
note that the percentage of l1 B cells is reduced after the
PGK-neo deletion (S/S) to even lower levels than in wild-
type mice (G/G; Fig. 3; see below).
To check whether the PGK-neo can advance VJ recom-
bination into an earlier B cell stage, we sequenced the
Vl1Jl1 coding joints from splenic B cells of the S-n/S-n
targeted mice (Table II). N region nucleotide addition was
found in only 1 of 14 joints, similar to the light chain N ad-
dition frequency in l1 genes of normal mice. The VD and
DJ joints of IgH chain genes, which rearrange at the pro-B
to early pre-B cell stages, have a high frequency of N addi-
tions due to TdT expression (30). Thus, using N additions
as a measure of B cell stage, we conclude that PGK-neo
cannot drive VJ recombination of l1 to the early B cell
stages at which IgH genes rearrange. As expected from a
random sample, only about 1/3 of the rearrangements were
in frame (productive; Table II).
The LoxP Site Inhibits VJ Recombination in the Targeted l1
Locus. The targeted mice with a complete PGK-neo de-
letion (S/S) have a lower level of l1 B cells than the wild-
type mice: the S/S mice have only 15.8% l1 B cells (6.07/
38.36% of total B cells) compared with 52.5% l1 B cells
(20.38/38.78%) in the G/G wild-type mice (Fig. 3). This
Figure 3. l1 B cells in bone marrow and spleen after
neo deletion. The analysis was done as in the legend to
Fig. 2 A. A representative analysis from k2/2 G/G, G/S,
and S/S mice is shown. Spleens were bisected. One half
was used to do a Southern blot (similar to Fig. 1 D; data
not shown) confirmed that neo was completely deleted.
The other half was used for the FACS® analysis.705 Sun and Storb
effect is unlikely to be caused by mouse strain polymor-
phisms, as the mice were bred with k2/2 mice, basically on
a C57BL/6 background. Also, among the strains we used,
129 and C57BL/6, the l1 expression is always close to 55–
60% of the total l B cells (31). However, the decreased l1
expression from the targeted allele could be caused by the
serine codon mutation or by the loxP site left on the chro-
mosome. If serine at position 154 of the Cl1 region de-
creases the signaling efficiency of the l1 B cell receptor, B
cell development could be affected, which in turn could
reduce the mature l1 B cell numbers. However, based on
the comparison of the percentages of immature l1 B cells
(mainly in the bone marrow) with mature B cells (spleen),
the serine substitution does not inhibit the development
from the immature to the mature B cell stage. The ratio of
l1/l21l3 in spleen is 75% of that in bone marrow in the
G/G mice, and 70% in the S/S mice (Fig. 3, and data not
shown). Thus, the S/S l1 B cells survive as well as the G/G
B cells during B cell maturation from the bone marrow to
the spleen stage.
To directly test whether the l1 deficiency after elimina-
tion of PGK-neo was caused by inefficient VJ recombina-
tion, we purified l1 and l2/l3 B cells separately from a
heterozygous mouse (G/S) spleen by cell sorting. Semi-
quantitative PCR was employed to amplify the rearranged
l1 genes from each DNA sample (Fig. 4 A). After Asp718
digestion, the wild-type versus targeted rearranged bands
can be distinguished (Fig. 4, A and B). The rearranged
wild-type l1 band is four times stronger than the targeted
l1 band in l2/l3 B cells, and there is a similar difference
in l1 B cells (Fig. 4 B). We next sequenced the l1 VJ se-
quences from l2/l3 B cells. All of the sequences (18/18)
are nonproductively rearranged (the majority are from the
wild-type allele), whereas the sequences from l1 B cells are
all functional (7/7; Table III). The absence of productive
l1 rearrangements in l2/3 cells has also been found in nor-
mal mice (32). It probably indicates that in general, l1 is
rearranged before l2 or l3, thus allowing l2/3 rearrange-
ment mainly if l1 is nonproductively rearranged. On the
other hand, the finding that all seven out of seven l1 se-
quences obtained from l1 B cells of G/S mice were from
the wild-type, G, allele further indicates that the wild-type
allele is rearranged much more efficiently than the mutant
S allele. Also, if the wild-type l1 allele is nonproductively
Table II. VJ Joints of l1 Light Chain Genes
Vl1 region
N
region Jl1 region Productivity
AGC AAC CAT TTC C TGG GTG TTC
1 AGC AAC CAT TT– – ––G GTG TTC 1
2 AGC AAC CAT TT– – –GG GTG TTC 2
3 AGC AAC CA– ––– C TGG GTG TTC 1
4 AGC AAC CAT TTC T – ––– GTG TTC 2
5 AGC AAC CAT TT– – –GG GTG TTC 2
6 AGC AAC CAT T–– – –GG GTG TTC 1
7 AGC AAC CAT T–– – –GG GTG TTC 1
8 AGC AAC CAT TT– – –GG GTG TTC 2
9 AGC AAC CAT TT– – –GG GTG TTC 2
10 AGC AAC CAT TTC – –GG GTG TTC 2
11 AGC AAC CAT TTC – –GG GTG TTC 2
12 AGC AAC CAT TT– – TGG GTG TTC 2
13 AGC AAC CAT TT– – –GG GTG TTC 2
14 AGC AAC CAT TT– – –GG GTG TTC 2
VJ joints of l1 light chain genes from the splenic DNA of a k2/2 S-n/
S-n mouse. The germline coding end sequences adjacent to the RSSs in
the Vl1 and Jl1 regions are shown underlined on the top. Each line
represents an individual clone. Nucleotides deleted at the coding ends
are indicated by dashes. N nucleotides are shown as an underlined italic
letter in the middle column. Productivity: the joint results in an in-frame
(1) or out-of-frame (2) J region.
Figure 4. VJ rearrangement in the targeted allele without neo. (A)
Schematic structure of the l1 genomic locus and its rearranged DNA
product. Location of primers used for PCR are shown by small arrows.
The gray box indicates the probe (see Fig. 1 A, probe B) used in the
Southern blot in B. The PCR product of the rearranged wild-type allele
contains a KpnI/Asp718 site whereas that of the targeted allele does not.
(B) Southern blot with the J1XbaI-C1KpnI probe (see Fig. 1 A, probe B)
on the rearranged VJl1 PCR products from DNA of either sorted splenic
B cells or total spleen. l1 and l21l3 B cells were sorted separately from
a k2/2 G/S mouse spleen. The spleen DNAs from k2/2 G/G, S/S, and
G/S-n mice were included as controls. All the PCR products were di-
gested by Asp718 and the sample from k2/2 G/G was used as the com-
plete digestion control. “R” stands for “rearranged.” The bands were
quantitated and gave the following ratios: in G/S mice, the S/G ratio in
l2/3 B cells was 1:4, and in l1 B cells it was 1:3.8. In G/S-n mice, the
S-n/G proportion in total spleen was 5:1. For G/S-n mice either 35, left
lane, or 30, right lane, PCR cycles were used. The higher MW bands in
spleen are undefined PCR artifacts.706 Ig Gene Accessibility
rearranged, the cell then apparently has a greater chance to
rearrange l2/3 than to rearrange the targeted l1 gene (S)
allele (see also Fig. 3, G/S and S/S). The nonproductive l1
in l2/3 B cells could not have been selected on the protein
level and could thus not be affected by the serine mutation.
The levels of the rearranged bands (Fig. 4 B) thus directly
reflect the VJ recombination efficiency of the correspond-
ing alleles. Therefore, after removal of PGK-neo, the tar-
geted allele does have reduced l1 VJ recombination, which
could only be caused by the loxP site left on the chromo-
some.
The Levels of Jl1 Germline Transcripts Are Correlated with
the Efficiency of VJ Recombination in S-n, S, and G Alleles.
To determine the relationship between VJ recombination
efficiencies and germline transcription activity, we mea-
sured the levels of Jl1 germline transcripts in heterozygous
mice before and after deletion of PGK-neo and in the
wild-type l1 locus. The Igl light chain genes normally
start to rearrange at the small pre-B cell stage, at which
time Jl germline transcription is found (17). We sorted
small pre-B (IgM2B2201CD251, small) as well as large
(less mature) pre-B cells (IgM2B2201CD251, large) from
the bone marrow of two G/S-n heterozygous mice. RT-
PCR and restriction digestion were performed to distin-
guish the germline transcript levels from the two different
alleles (Fig. 5). At the small pre-B cell stage, the level of
germline transcripts is 1.6 to 5.9 times higher from the tar-
geted allele (S-n) than from the wild-type allele (G). A
much greater difference is observed in less mature large
pre-B cells. Transcripts from the targeted allele are present
at similar levels as in small pre-B cells by semiquantitative
estimation relative to b-actin, but no transcripts from the
Table III. Sequence Analysis of the Rearranged l1 Gene
Germline sequences Productivity
Vl1-AAC CAT TTC
From l2/3
B cells
1 AAC CAT ––– – –GG GTG TTC GGT 2
2 AAC CAT ––– C TGG GTG TTC GGT 2
3 AAC CAT ––– AG C TGG GTG TTC GGT 2
4 AAC CAT TT– – TGG GTG TTC GGT 2
5 AAC CAT TT– G – –GG GTG TTC GGT 2
6 AAC CAT ––– C TGG GTG TTC GGT 2
7 AAC CAT TT– – –GGGTG TTC GGT 2
8 AAC CAT ––– – –GGGTG TTC GGT 2
9 AAC CAT TTC – –GGGTG TTC GGT 2
10 AAC CAT TT– – –GGGTG TTC GGT 2
11 AAC CAT ––– C TGG GTG TTC GGT 2
12 AAC CAT TTC GAA – ––G GTG TTC GGT 2
13 AAC CAT TTC – ––G GTG TTC GGT 2
14 AAC CAT TT– – –GG GTG TTC GGT 2
15 AAC CAT TT– – –GG GTG TTC GGT 2
16 AAC CAT ––– G C TGG GTG TTC GGT 2
17 AAC CAT ––– – –GG GTG TTC GGT 2
18 AAC CAT TT– – –GG GTG TTC GGT 2
From l1
B cells
1 AAC CAT T–– – –GG GTG TTC GGT 1
2 AAC CAT ––– – TGG GTG TTC GGT 1
3 AAC CAT TT– – ––G GTG TTC GGT 1
4 AAC CAT T–– – –GG GTG TTC GGT 1
5 AAC CAT T–– – –GG GTG TTC GGT 1
6 AAC CAT T–– – –GG GTG TTC GGT 1
7 AAC CAT T–– – –GG GTG TTC GGT 1
Sequence analysis of the rearranged l1 gene in either sorted l1 or sorted
l21l3 B cells from a k2/2 G/S mouse. The germline sequences of Vl1
and Jl1 coding ends are shown at the top. Independent clones from the
sorted B cells are shown below. Nucleotides deleted at the coding ends
are indicated by dashes. P (palindromic) elements are shown in italics. N
nucleotides are shown as underlined italics. Productivity: 1 (2), the
gene is productively (nonproductively) rearranged.
Figure 5. Germline transcription levels of Jl1 in k2/2 G/S-n and G/S
mice. (A) Schematic structure of the Jl1 germline transcripts. The germ-
line transcripts are initiated 59 of the J region and spliced to the C region.
Location of primers used for RT-PCR are shown by small arrows. The
gray box indicates the probe (see Fig. 1 A, probe B) used in the Southern
blot in Fig. 6 B. The PCR product of the wild-type allele contains a
KpnI/Asp718 site whereas that of the targeted allele does not. (B) South-
ern blot of the RT-PCR products of the germline transcripts from the in-
dicated cell stage/lineage. The RT-PCR products were digested by
Asp718 (indicated as “Cut”) to distinguish products from the wild-type
and targeted alleles. The blots were hybridized with the J1XbaI-C1KpnI
probe. Germline transcripts corresponding to the targeted or the wild-
type alleles are indicated. The experiments from two dilutions of thymus
sample are shown. No amplification products were obtained when re-
verse transcriptase was omitted from the reaction of all the samples (two
are shown as “RNA,” others not shown).707 Sun and Storb
wild-type allele can be found. The absence of germline l1
transcripts in large pre-B cells of wild-type mice has also
been observed by Engel et al. in normal mice (17). In addi-
tion, T cells also show high Jl1 transcription from the tar-
geted allele (Fig. 5 B). The high transcript level from the
targeted allele is most likely due to the ubiquitously active
strong PGK promoter. However, transcription alone is not
sufficient for VJl1 rearrangement in large pre-B cells (Ta-
ble II) and T cells (Fig. 2 C; see Discussion).
To compare the expression of the wild-type and targeted
alleles after neo deletion we sorted pre-B cells (IgM2
B2201) from the heterozygous G/S mouse bone marrow.
The germline transcripts from these cells are clearly biased
to the wild-type allele (Fig. 5 B). Coincidentally, in these
mice, VJ recombination also preferably occurs at the wild-
type allele (Fig. 4). Thus, the germline transcript levels ex-
actly parallel the recombination efficiencies from the high-
est in PGK-neo containing (S-n), through the intermediate
in wild-type (G), to the lowest in PGK-neo deleted (S) l1
alleles.
Mapping of the Germline Jl1 Promoter. To understand
the relationship between the inserted PGK-neo gene and
the germline Jl1 promoter we determined the position of
this promoter. Jl1 germline transcription was found previ-
ously in wild-type mice, but the transcript initiation site
was not defined in mice (17). To map the promoter, a se-
ries of 13 59 primers were used that are located 59 of Jl1,
together with a 39 primer in Cl1 to amplify oligo-dT-
primed cDNAs from pre-B cells of l wild-type mice. As
shown in Fig. 6 A, primers located up to 269 nucleotides
upstream of the NdeI site gave a PCR product, whereas
primers located further upstream did not. The most 39 two
of the latter primers were found to amplify a correct sized
and sequenced product from genomic DNA; therefore, the
lack of cDNAs extending into this region is not due to in-
efficient primers. Thus, this analysis places the initiation of
the germline Jl1 transcript between primers JM014 and
JM015. There is a good candidate for a TATA box just up-
stream of primer JM014 which would place the transcrip-
tion start site at about the G located 29 nucleotides 39 of
the putative TATA box (Fig. 6 B). This start site is six nu-
cleotides 59 of the 39 end of primer JM014, making the
primer overlap too short for stable annealing. Thus, the
start of the Jl1 germline transcript is located 420 nucle-
otides 59 of Jl1 in the untargeted l locus (Fig. 6 B). In the
targeted locus it resides 336 nucleotides 59 of the inserted
PGK-neo gene and 1 kb 59 of the start of the neo gene
transcripts.
Do All Jl1 Germline Transcripts from the Targeted Allele Ini-
tiate from the PGK Promoter? Jl1-containing transcripts in
thymus and large pre-B cells of G/S-n mice are all from the
targeted allele (Fig. 5 B). These transcripts must initiate
from the PGK promoter, as none are found that initiate
upstream of this promoter in the targeted allele of G/S-n
mice (Fig. 6 C). On the other hand, in small pre-B cells,
Jl1-containing transcripts arise from both the targeted and
the wild-type allele in G/S-n mice (Fig. 5 B). Interestingly,
in these cells transcripts are found that start upstream of the
PGK promoter and most likely initiate at the germline Jl1
promoter. Thus, this promoter is only active in small pre-B
cells when the l enhancers are activated and VJ recombi-
nation takes place, even in the presence of PGK-neo.
Discussion
Jl1 Germline Transcription and VJ Recombination Is Pro-
moted by the PGK-Neo Insertion. When PGK-neo is inserted
in the k or heavy chain intron, in most cases it causes
strong inhibition of V(D)J recombination (3, 9, 10, 18–20).
A similar phenotype has also been observed in the TCR
loci (33). This was postulated to be due to the higher den-
sity of CpGs in the coding sequence of the neo gene (18)
or to the neo coding region itself (34). Alternatively, it may
be due to a squelching effect, in which the PGK promoter
interacts with the Ig enhancer at the expense of an Ig pro-
moter/enhancer interaction (9, 10). In our experiment, the
location of the PGK promoter relative to the germline Jl1
promoter and the El3-1 enhancer is such that the PGK
promoter initiates transcripts that pass through the RSS.
Therefore, instead of possibly interfering with the germline
transcription of the JC l1 region, a strong PGK promoter
in this case promotes transcription through Jl1. However,
similar to findings by others (35) transcription alone is not
sufficient for rearrangement (see below).
The Jl1 Germline Transcription Is Inhibited by the LoxP
Site. A single remnant loxP site with its short flanking re-
gion dramatically inhibits VJ recombination. This is proba-
bly a consequence of the severe inhibition of Jl1 germline
transcription by this loxP remnant (Fig. 5). We consider
two possible reasons. The remnant loxP site is very rich in
CpG dinucleotides. As CpGs are substrates for DNA meth-
ylation, methylated CpGs may be involved in inactivating
the region, leading to the repression of Jl1 germline tran-
scription. It has been shown that hypomethylation is corre-
lated with V(D)J recombination activity (36–38).
Alternatively, the additional 150 nucleotides of the rem-
nant loxP site might directly interfere with transcription
initiation from the Jl1 promoter. In another study, a loxP
remnant was reported to have no effect on VJ recombina-
tion in the Igk locus, nor to affect Jk germline transcription
(39). In that study, the loxP site was located farther away
from the Jk RSS (2 kb). Also, the flanking region of the
loxP site was different from ours.
Finally, the loxP site remaining in the “S” mutation may
disrupt a Jl proximal regulatory element similar to the kI/
kII sequences which are important for Jk gene rearrange-
ment (39).
As the cre-loxP system is extensively used to eliminate
potential effects of the selectable marker in targeted loci, it
is important to consider possible consequences of retaining
a loxP site. The loxP flanked marker gene should be placed
at a safe distance from any essential control element, and
the constitution of the polylinker region should be consid-
ered.708 Ig Gene Accessibility
The Levels of Jl1 Germline Transcription Are Highly Corre-
lated with VJ Recombination. What is the molecular mech-
anism for the PGK-neo effect? As the PGK promoter is a
strong housekeeping promoter, it is presumably active in
all cells. Clearly, transcripts from the S-n allele initiating
upstream of Jl1 can be detected in both large pro-, pre-B
cells (stages A–C of the Hardy nomenclature [40]) and in
T cells, where germline transcripts from the wild-type al-
lele are not found (Figs. 5 and 6). Nevertheless, Jl1 germ-
line transcription is not sufficient to promote l1 rearrange-
ment in either T cells or in the early B cell stage (Fig. 2 C).
We find no rearranged l1 band in the thymus from an S-n/
S-n mouse (Fig. 2 C). The Vl1Jl1 joints found in the
S-n/S-n homozygous targeted mice do not show an in-
crease in N additions (Table II), as would be expected if
the rearrangement took place as early as Ig heavy chain
gene rearrangement in B cell development when TdT is
expressed (41).
Figure 6. The germline Jl1 promoter. (A) Map and RT-PCR primers
used to identify the endogenous Jl1 germline transcription initiation site.
The endogenous l1 locus is shown in the top three lanes, with the posi-
tion of the NdeI site, where PGK-neo is inserted in the targeted S-n al-
lele. The position of each upstream primer used is shown, with the num-
ber indicating the distance (in basepairs) between the 59 end of the primer
and the NdeI site. The downstream primer used for RT-PCR was
39J3C1, located in the Cl1 exon. The names of the primers are in brack-
ets. The position of the potential initiation site is marked with a black ar-
row. DNA PCR: four primers tested and found positive in PCR amplifi-
cation of genomic DNA with the 39J3C1 downstream primer. The
position of the primer used in C, 39PNR-2, is shown. (B) Sequences 461
to 1,952 between Cl3 and Jl1 were not previously sequenced. Exons
and nonamer/heptamer are marked by solid and dotted underlines, re-
spectively. The primers JM014 and JM015 are indicated by dotted lines
with arrows. The potential TATA box and the transcriptional start site are
indicated. (C) RT-PCR to detect germline transcripts from the endogen-
ous promoter in the S-n targeted allele. The primers, JM001 and 39PNR-2
(see A), were used for PCR reactions with cDNA or RNA of the indi-
cated cell types from a G/S-n mouse. The germline transcription prod-
ucts (248 bp) are indicated as “PGK junction.” G/S-n thymus DNA sam-
ple and positive ES clone DNA were included as positive PCR controls.
b-actin was included as the cDNA quantity control.709 Sun and Storb
The lack of VJl1 rearrangement in thymus and large
preB cells of S-n/S-n mice is not due to lack of Vl1 germ-
line transcription. Surprisingly, Vl1 germline transcripts
are apparently present in both large pre-B cells and thymus
RNA (not shown). We also found Vl1 germline tran-
scripts in thymus RNA from wild-type mice (data not
shown). We consider two possibilities: The germline tran-
scription of Vl1 might not reflect the same chromatin
structure alteration required for V(D)J recombination in
the J region. Indeed, a recent study showed an unusual
profile of germline transcription, nuclease sensitivity, and
methylation of the V regions in the TCR-b locus, suggest-
ing that the V region might use a unique structural confor-
mation to be accessed by the V(D)J recombinase complex
(42). Second, the germline transcription of Vl1 might sug-
gest constitutively open chromatin at that region in B and
T cells. Therefore, the V(D)J recombination complex may
be able to access Vl1 region all the time. Thus, the lack of
rearrangement of the S-n allele in large pre-B and T cells
most likely indicates that rearrangement also requires acti-
vation of the l enhancers by transactivating factors and that
this does not occur until the small pre-B stage, when l1 re-
arrangement normally takes place. At this stage, the germ-
line Jl1 promoter is active (Fig. 6) and all other required
elements for l1 rearrangement are functional.
In small pre-B cells, the level of the germline transcripts
from the S-n allele is clearly higher than that from the
wild-type allele (Fig. 5 B). It is possible that there is a dif-
ference in the stability between the endogenous and the
PGK-neo inserted transcripts. However, as Ig transcripts,
generally, are very stable, there is no reason to expect that
the wild-type transcripts would be less stable than the tran-
scripts from the targeted locus. Therefore, the presence of
PGK-neo upstream of the Jl1 RSS most likely causes up-
regulation of germline transcription. There are at least two
possible models how the levels of germline transcription
may affect l1 rearrangement efficiency. In G/S-n mice, the
increased germline transcription of the targeted allele com-
pared with the wild-type allele could represent a more
completely opened chromatin around the Jl1 RSS via
ATP-dependent remodeling and acetylation of histones
(43, 44). The more open RSS configuration would be
more accessible to limiting quantities of V(D)J recombina-
tion components. Conversely, in the neo-deleted mice, in
the presence of the CpG-rich loxP remnant, chromatin
condensation could persist via the binding of methylated
DNA binding proteins and possible recruitment of histone
deacetylases (43, 45). The chromatin condensation could
make the RSS directly inaccessible or prevent transcription
from the germline Jl1 promoter.
Alternatively, the germline transcription complexes
themselves could be involved in the upregulation of VJ re-
combination. In light of the previous findings of inhibition
of rearrangement by PGK-neo when inserted into the JC
intron and transcribing away from the RSS, our findings
would be well explained by an enhancement of V(D)J re-
combination by transcription through the RSS. Perhaps
components of the V(D)J recombinase could be associated
with transcription complexes during transcript elongation
and be more efficiently deposited at the RSS. It is likely
that open chromatin exists in small pre-B cells at both the
wild-type and S-n Jl1 RSSs, as transcripts are seen. How-
ever, in an S-n allele with the PGK promoter, transcript
initiation occurs at a higher rate allowing more transcrip-
tion complexes to clear the promoter and possibly to carry
V(D)J recombination factors to the RSS during transcript
elongation. It would be interesting to turn around the PGK
promoter both in the l and k loci. Perhaps, no more en-
hancement of Jl1 rearrangement would be found, because
the PGK initiated transcripts do not pass through this RSS
anymore. Further, if directionality is not an issue, k gene
rearrangement may actually be enhanced by transcripts
passing through the Jk RSS in the opposite orientation.
However, to boost rearrangement, the transcripts may
have to initiate at an Ig germline promoter. The presence of
enhancer elements in PGK-neo may nonspecifically upreg-
ulate transcription from the germline Jl1 promoter when
the l enhancers are active. It appears that there are more
transcripts initiating at the PGK promoter than at the germ-
line Jl1 promoter in small pre-B cells (not shown). How-
ever, it is possible that the majority of the transcripts are
from small pre-B cells that are unable to rearrange VJl1.
It is clear that the accessibility to V(D)J recombination is
controlled at several levels besides the requirement for the
recombinase complex. Every Ig or TCR gene segment has
not only its own RSS but also its own germline promoter
whose activity is required for V(D)J recombination. RSS
strength has been shown to affect the recombination fre-
quencies (46–48). Our findings suggest that there is a po-
tential secondary level of control in which the absolute ac-
tivity of a germline promoter determines the absolute
efficiency of recombination. The gene segment carrying a
strong promoter will have a greater chance to be rear-
ranged than the one with a weak promoter in the same lo-
cus. This, besides RSS quality, may explain the different
intrinsic rearrangement efficiencies of different V, (D), and
J regions in the Ig and TCR loci.
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